Stay updated on Poziotinib in NSCLC with EGFR/HER2 Insertion Clinical Trial

Sign up to get notified when there's something new on the Poziotinib in NSCLC with EGFR/HER2 Insertion Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Poziotinib in NSCLC with EGFR/HER2 Insertion Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    A new site revision entry v3.6.6 was added to the change log, and the prior revision v3.6.5 was removed. This indicates a maintenance/patch update to the site, not a change to the study content or functionality.
    Difference
    0.0%
    Check dated 2026-08-30T06:49:21.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    The page now lists Revision: v3.6.5, replacing the previous Revision: v3.6.4. This indicates a minor update to the page's versioning information.
    Difference
    0.0%
    Check dated 2026-08-08T23:14:34.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.3 to v3.6.4, indicating a newer version of the page content. This reflects an update to the page text or layout.
    Difference
    0.0%
    Check dated 2026-07-25T14:07:09.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    A newer revision identifier appears on the page, indicating a backend or template update; the study content and user-facing information remain unchanged.
    Difference
    0.0%
    Check dated 2026-07-04T04:54:01.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    The page revision label has been updated from v3.6.0 to v3.6.2, indicating a newer version of the ClinicalTrials.gov study page.
    Difference
    0.0%
    Check dated 2026-06-27T02:55:15.000Z thumbnail image
  8. Check
    85 days ago
    Change Detected
    Summary
    The study page now indicates recruitment is closed and results have been posted. New navigation/help sections were added (How to Read a Study Record, Common Questions, How to Join a Study), and the 28-day treatment cycle duration is stated.
    Difference
    6%
    Check dated 2026-06-12T16:53:09.000Z thumbnail image

Stay in the know with updates to Poziotinib in NSCLC with EGFR/HER2 Insertion Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Poziotinib in NSCLC with EGFR/HER2 Insertion Clinical Trial page.